HCW Biologics (HCWB) Profit After Tax (2020 - 2025)
HCW Biologics' (HCWB) quarterly Profit After Tax came in at $719232.0 in Q4 2025, up 121.32% YoY from $324971.6 in Q4 2024, and up 115.79% on a QoQ basis from -$4.6 million in Q3 2025.
HCW Biologics (HCWB) Profit After Tax (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Profit After Tax data on file, last reported at $719232.0 in Q4 2025.
- Quarterly Profit After Tax rose 121.32% year-over-year to $719232.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$8.0 million (up 73.49% YoY) and the FY2025 annual result came in at -$8.0 million, up 73.49% from the prior year.
- Profit After Tax advanced to $719232.0 in Q4 2025, from -$4.6 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $719232.0 in Q4 2025 to a low of -$15.3 million in Q2 2024.
- A 5-year average of -$4.5 million and a median of -$3.9 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2024 — Profit After Tax slumped 254.99% — and 2025, when it surged 121.32%.
- Tracing HCWB's Profit After Tax over 5 years: stood at -$3.2 million in 2021, then sank by 70.75% to -$5.4 million in 2022, then slumped by 97.1% to -$10.7 million in 2023, then soared by 68.42% to -$3.4 million in 2024, then jumped by 121.32% to $719232.0 in 2025.
- The last three Profit After Tax figures came in at $719232.0 (Q4 2025), -$4.6 million (Q3 2025), and -$1.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 164.49 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -16.62 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -355.03 Mn |
| 10 | HCW Biologics | 2.93 Mn | 2.19 Mn | -93,887.00 | -5.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 719,232.00 |
| Sep 30, 2025 | -4.55 Mn |
| Jun 30, 2025 | -1.93 Mn |
| Mar 31, 2025 | -2.20 Mn |
| Dec 31, 2024 | -3.37 Mn |
| Sep 30, 2024 | -3.90 Mn |
| Jun 30, 2024 | -15.28 Mn |
| Mar 31, 2024 | -7.47 Mn |
| Dec 31, 2023 | -10.68 Mn |
| Sep 30, 2023 | -4.94 Mn |
| Jun 30, 2023 | -4.30 Mn |
| Mar 31, 2023 | -5.07 Mn |
| Dec 31, 2022 | -5.42 Mn |
| Sep 30, 2022 | -3.91 Mn |
| Jun 30, 2022 | -3.51 Mn |
| Mar 31, 2022 | -2.06 Mn |
| Dec 31, 2021 | -3.17 Mn |
| Sep 30, 2021 | -4.09 Mn |
| Jun 30, 2021 | -2.75 Mn |
| Mar 31, 2021 | -2.84 Mn |